[PDF][PDF] Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
…, ES Theel, MJ Liebeskind, B Alford, WJ Buchser… - Cell host & …, 2021 - cell.com
Neutralizing antibodies against the SARS-CoV-2 spike (S) protein are a goal of COVID-19
vaccines and have received emergency use authorization as therapeutics. However, viral …
vaccines and have received emergency use authorization as therapeutics. However, viral …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
…, GF Wu, SPJ Whelan, WJ Buchser… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
Rapid and extraction-free detection of SARS-CoV-2 from saliva by colorimetric reverse-transcription loop-mediated isothermal amplification
…, WJ Buchser, RD Head, RD Mitra, J Milbrandt - Clinical …, 2021 - academic.oup.com
Background Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19
pandemic. Current gold-standard nucleic acid tests are hampered by supply shortages …
pandemic. Current gold-standard nucleic acid tests are hampered by supply shortages …
[HTML][HTML] Defining the risk of SARS-CoV-2 variants on immune protection
…, EA Boritz, DL Bratt, TL Bricker, L Brown, WJ Buchser… - Nature, 2022 - nature.com
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …
variants jeopardizes the protective antiviral immunity induced after infection or …
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
S Munich, A Sobo-Vujanovic, WJ Buchser… - …, 2012 - Taylor & Francis
Autocrine and paracrine cell communication can be conveyed by multiple mediators,
including membrane-associate proteins, secreted proteins and exosomes. Exosomes are 30–100 …
including membrane-associate proteins, secreted proteins and exosomes. Exosomes are 30–100 …
[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2
…, RM Presti, GF Wu, SPJ Whelan, WJ Buchser… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
[HTML][HTML] Zinc in innate and adaptive tumor immunity
E John, TC Laskow, WJ Buchser, BR Pitt… - Journal of translational …, 2010 - Springer
Zinc is important. It is the second most abundant trace metal with 2-4 grams in humans. It is
an essential trace element, critical for cell growth, development and differentiation, DNA …
an essential trace element, critical for cell growth, development and differentiation, DNA …
Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
…, ES Theel, MJ Liebeskind, B Alford, WJ Buchser… - BioRxiv, 2020 - biorxiv.org
Although neutralizing antibodies against the SARS-CoV-2 spike (S) protein are a goal of
most COVID-19 vaccines and being developed as therapeutics, escape mutations could …
most COVID-19 vaccines and being developed as therapeutics, escape mutations could …
Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression
X Liang, ME De Vera, WJ Buchser… - Cancer research, 2012 - AACR
Administration of high-dose interleukin-2 (HDIL-2) has durable antitumor effects in 5% to 10%
of patients with melanoma and renal cell carcinoma. However, treatment is often limited by …
of patients with melanoma and renal cell carcinoma. However, treatment is often limited by …
Cell-mediated autophagy promotes cancer cell survival
WJ Buchser, TC Laskow, PJ Pavlik, HM Lin, MT Lotze - Cancer research, 2012 - AACR
Immune effector cells integrate signals that define the nature and magnitude of the subsequent
response. Experimental measures for immune cell–mediated lysis of tumors or virally …
response. Experimental measures for immune cell–mediated lysis of tumors or virally …